Watch the recorded educational event on cIMPACT-NOW: Advancing the Molecular Classification of Ependymal Tumors
National Brain Tumor Society and the CERN Foundation hosted a virtual educational event on the new ependymoma molecular classification updates released in the
cIMPACT now update 7 publication on Thursday, September 10, 2020 at 12pm. Dr. David Ellison, Chair of Pathology at St. Jude Children’s Research Hospital, and Dr. Mark Gilbert, Chief of the Neuro Oncology Branch at the National Institutes of Health, were interviewed by Kim Wallgren to help educate patients and care partners on how molecular classification is done, why it is important to the community, and explaining the recent updates involving ependymoma.
“We know for ependymoma, really important molecular advances have been made that allow us to separate out tumors that look the same down the microscope, but actually have key biological differences.”
— Dr. David Ellison, Chair of Pathology at St. Jude Children’s Research Hospital
